Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
Open Access
- 12 January 2014
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (2) , 462-472
Abstract
L1CAM promotes cell motility, invasion and metastasis formation in various human cancers and can be considered as a driver of tumor progression. Knowledge about genetic processes leading to the presence of L1CAM in cancers is of considerable importance. Experimentally, L1CAM expression can be achieved by various means. Overexpression of the transcription factor SLUG or treatment of cells with TGF-β1 can induce or augment L1CAM levels in cancer cells. Likewise, hypomethylation of the L1CAM promoter on the X chromosome correlates with L1CAM expression. However, presently no mechanisms that might control transcriptional activity are known. Here we have identified miR-34a as a suppressor of L1CAM. We observed that L1CAM positive endometrial carcinoma (EC) cell lines HEC1B and SPAC1L lost L1CAM protein and mRNA by treatment with demethylating agents or knock-down of the DNA-methyltransferase-1 (DNMT1). Concomitantly, several miRNAs were up-regulated. Using miRNA profiling, luciferase reporter assays and mutagenesis, we identified miR-34a as a putative binder to the L1CAM-3’UTR. Overexpression of miR-34a in HEC1B cells blocked L1CAM expression and inhibited cell migration. In ECC1 cells (wildtype p53) the activation of p53 caused miR-34a up-regulation and loss of L1CAM expression that was miR-34a dependent. We observed an inverse correlation between L1CAM and miR-34a levels in EC cell lines. In primary tumor sections areas expressing high amounts of L1CAM had less miR-34a expression than those with low L1CAM levels. Our data suggest that miR-34a can regulate L1CAM expression by targeting L1CAM mRNA for degradation. These findings shed new light on the complex regulation of L1CAM in human tumors.Keywords
This publication has 33 references indexed in Scilit:
- MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung CancerPLOS ONE, 2013
- MicroRNAs in the p53 network: micromanagement of tumour suppressionNature Reviews Cancer, 2012
- L1CAMCell Adhesion & Migration, 2012
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitionsCell Cycle, 2011
- Wild-type p53 controls cell motility and invasion by dual regulation of MET expressionProceedings of the National Academy of Sciences, 2011
- Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancerOncogene, 2011
- Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cellsInternational Journal of Oncology, 2010
- L1CAM malfunction in the nervous system and human carcinomasCellular and Molecular Life Sciences, 2010
- The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodiesOncogene, 2007
- Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response.Oncology Reports, 2004